← Leaderboards
Jody Corey-Bloom
University Of California San Diego
$3,079,845
Attributed
$3,079,845
Total exposure
19
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $265.4K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,079,845 · 19
By mechanism
P50$2,712,268 · 3
M01$367,577 · 16
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Gerard David Schellenberg$94,178,901
- Pamela L Mellon$36,611,301
- Ajit P Varki$39,470,453
- Jeff M Hasty$24,639,672
- Bruce A Hamilton$25,822,597
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesResearch PersonnelClinical ResearchSourceFundingUnited States National Institutes Of HealthInstitutionGrantComputer Retrieval Of Information On Scientific Projects DatabaseCaregiversTrainingResearch StudyHuntington DiseaseDementiaAlzheimer&AposSkillsS DiseaseProgramsPhysiciansCommunitiesElderlyHealth ProfessionalHispanicsSupport Groups
Grant awards (33)
Outreach, Recruitment and Education Core$225,736
P50 · FY2018 · AG · contact PI
Outreach, Recruitment and Education Core$225,818
P50 · FY2017 · AG · contact PI
Outreach, Recruitment and Education Core$214,762
P50 · FY2016 · AG · contact PI
Outreach, Recruitment and Education Core$209,538
P50 · FY2015 · AG · contact PI
Outreach, Recruitment and Education Core$214,762
P50 · FY2014 · AG · contact PI
Education and Information Transfer Core E$166,815
P50 · FY2013 · AG · contact PI
Education and Information Transfer Core E$188,984
P50 · FY2012 · AG · contact PI
Education and Information Transfer Core E$178,243
P50 · FY2011 · AG · contact PI
Education and Information Transfer Core E$180,009
P50 · FY2010 · AG · contact PI
CLINICAL TRIAL: ACR16 VERSUS PLACEBO FOR THE SYMPTOMATIC TREATMENT OF HUNTINGTON$14,497
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)$11,736
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: PHASE 3 STUDY OF DIMEBON IN PATIENTS WITH MILD-TO-MODERATE HUNTI$6,385
M01 · FY2010 · RR · contact PI
FRONTOSTRIATAL ACTIVATION IN SUBJECTS AT RISK FOR HUNTINGTON'S DISEASE$3,107
M01 · FY2010 · RR · contact PI
Education and Information Transfer Core E$176,500
P50 · FY2009 · AG · contact PI
CLINICAL TRIAL: A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTI$32,838
M01 · FY2009 · RR · contact PI
FRONTOSTRIATAL ACTIVATION IN SUBJECTS AT RISK FOR HUNTINGTON'S DISEASE$20,382
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)$19,817
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: ACR16 VS PLACEBO FOR THE SYMPTOMATIC TREATMENT OF HUNTINGTON'S D$15,852
M01 · FY2009 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER$169,465
P50 · FY2008 · AG · contact PI
CLINICAL TRIAL: A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTI$44,421
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)$8,243
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: TRIAL OF ETHYL-EPA IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'$457
M01 · FY2008 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER$173,785
P50 · FY2007 · AG · contact PI
DETERMINE THE SAFETY AND TOLERABILITY OF PHENYLBUTYRATE IN HUNTINGTON'S DISEASE$14,341
M01 · FY2007 · RR · contact PI
A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTINGTON'S DISEASE$5,814
M01 · FY2007 · RR · contact PI
TRIAL OF ETHYL-EPA IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'S DISEASE$387
M01 · FY2007 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER$132,199
P50 · FY2006 · AG · contact PI
DETERMINE THE SAFETY AND TOLERABILITY OF PHENYLBUTYRATE IN HUNTINGTON'S DISEASE$25,752
M01 · FY2006 · RR · contact PI
SHORT TERM EFFECTS OF MEDICINAL CANNABIS ON SPASTICITY IN MULTIPLE SCLEROSIS$15,242
M01 · FY2006 · RR · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER$129,255
P50 · FY2005 · AG
SHORT TERM EFFECTS OF MEDICINAL CANNABIS ON SPASTICITY IN MULTIPLE SCLEROSIS$78,149
M01 · FY2005 · RR
CORE--EDUCATION AND INFORMATION TRANSFER$126,397
P50 · FY2004 · AG
Short Term Effects of Medicinal Cannabis on MS$50,157
M01 · FY2004 · RR